Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

Clinical trial NCT06898970 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06898970
Sponsor: Varun Monga, MBBS
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Angiosarcoma Angiosarcoma, Adult

Start date: 2026-01-09
Primary completion: 2029-10-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.